Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis

Published:2019-11 Issue: Volume:181 Page:111541
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Huang Zhi,Zhao Borui,Qin Zhongxiang,Li Yongtao,Wang Tianqi,Zhou Wei,Zheng Jianyu,Yang Shengyong^ORCID,Shi Yi,Fan Yan,Xiang Rong

Funder

Science and Technology Assistance in Developing Countries

Natural Science Foundation of Tianjin

Fundamental Research

Central Universities, Nankai University

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference40 articles.

1. Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma;Matta;Head Neck Oncol.,2009

2. Recent advances in the development of multi-kinase inhibitors;Krug;Mini Rev. Med. Chem.,2008

3. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors;Faivre;Semin. Oncol.,2006

4. Cyclins and cdks in development and cancer: a perspective;Deshpande;Oncogene,2005

5. Cell cycle, CDKs and cancer: a changing paradigm;Malumbres;Nat. Rev. Cancer,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of newer generation Vascular endothelial growth factor Receptor-2 Inhibitors: Pharmacophore based design, virtual Screening, molecular Docking, molecular dynamic Simulation, and DFT analyses;Journal of King Saud University - Science;2024-09

2. Advances in SHP2 tunnel allosteric inhibitors and bifunctional molecules;European Journal of Medicinal Chemistry;2024-09

3. Exploration of Potential Cyclin-dependent Kinases and their Inhibitors to Combat Abnormal Signalling and Cancer;Current Signal Transduction Therapy;2024-07

4. Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions;European Journal of Medicinal Chemistry;2024-06

5. Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma;Journal of Controlled Release;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3